LLY's non-obesity drugs like Verzenio and Taltz are fueling sales growth as investor focus stays on GLP-1 blockbusters.

The Delhi High Court has instructed India's drug regulator to address concerns about the approval process for drugs like ...

A PIL has claimed that licences for these drugs were issued without adequate data or India-specific trials and studies, ...

Just two days after Novo Nordisk launched Wegovy (semaglutide 2.4 mg) in India, Eli Lilly received regulatory approval for the KwikPen® format of its rival therapy Mounjaro (tirzepatide) ...

VK2735 shows strong early weight loss data, positioning Viking Therapeutics as a potential third major player in the booming GLP-1 obesity drug market. Learn more on VKTX stock here.

As obesity management draws awareness and weight-loss injections are launched in India, hospitals are offering customised ...

Eli Lilly and Company, Pfizer, Merck & Co., Inc., AbbVie, and Thermo Fisher Scientific are the five Pharmaceutical stocks to watch today, according to MarketBeat’s stock screener tool. Pharmaceutical ...

A nurse has warned about a common Mounjaro ‘mistake’ that can increase people’s risk of deadly organ damage.

Memorial Hermann is laying off 83 employees due to the closure of the University Place senior living community and nursing ...

Meadow Creek Wealth Advisors LLC decreased its position in Eli Lilly and Company (NYSE:LLY – Free Report) by 7.7% during the ...

The 10-year plan for the health service says there is a need to expand access to weight-loss services and treatments and ...

DelveInsight's Sleep Apnea Market Insights report includes a comprehensive understanding of current treatment practices, sleep apnea emerging drugs, market share of individual therapies, and current ...